NO20090327L - Nye forbindelser 384 - Google Patents

Nye forbindelser 384

Info

Publication number: NO20090327L
Authority: NO; Norway
Prior art keywords: compound; present; new connections; relates; formula
Prior art date: 2006-06-27

Application number

NO20090327A

Other languages

English (en)

Norwegian (no)

Inventor

Didier Rotticci

Tobias Rein

Ulrika Yngve

Fernando Huerta

Torben Pedersen

Karin Staaf

Jeremy Burrows

Fredrik Lake

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-27

Filing date

2009-01-21

Publication date

2009-02-09

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38846127&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20090327(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-01-21 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2009-02-09 Publication of NO20090327L publication Critical patent/NO20090327L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Psychiatry (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Psychology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Hospice & Palliative Care (AREA)
Endocrinology (AREA)
Hematology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyridine Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20090327A 2006-06-27 2009-01-21 Nye forbindelser 384 NO20090327L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US81675606P	2006-06-27	2006-06-27
PCT/SE2007/000620 WO2008002244A2 (fr)	2006-06-27	2007-06-26	Nouveaux composés 384

Publications (1)

Publication Number	Publication Date
NO20090327L true NO20090327L (no)	2009-02-09

Family

ID=38846127

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20090327A NO20090327L (no)	2006-06-27	2009-01-21	Nye forbindelser 384

Country Status (20)

Country	Link
US (1)	US20080188502A1 (fr)
EP (1)	EP2046782A4 (fr)
JP (1)	JP2009542638A (fr)
KR (1)	KR20090024817A (fr)
CN (1)	CN101511825A (fr)
AR (1)	AR061652A1 (fr)
AU (1)	AU2007265731A1 (fr)
BR (1)	BRPI0713576A2 (fr)
CA (1)	CA2655441A1 (fr)
CL (1)	CL2007001881A1 (fr)
CO (1)	CO6140059A2 (fr)
EC (1)	ECSP088973A (fr)
IL (1)	IL195666A0 (fr)
MX (1)	MX2008015720A (fr)
NO (1)	NO20090327L (fr)
RU (1)	RU2008148902A (fr)
TW (1)	TW200815418A (fr)
UY (1)	UY30440A1 (fr)
WO (1)	WO2008002244A2 (fr)
ZA (1)	ZA200810484B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2623374A1 (fr)	2005-09-30	2007-04-05	Astrazeneca Ab	Imidazo[1,2-a]pyridine a activite anti-proliferation cellulaire
AR058073A1 (es) *	2005-10-03	2008-01-23	Astrazeneca Ab	Derivados de imidazol 5-il-pirimidina, procesos de obtencion, composiciones farmaceuticas y usos
TW200811169A (en) *	2006-05-26	2008-03-01	Astrazeneca Ab	Chemical compounds
CL2007001873A1 (es) *	2006-06-27	2008-01-04	Takeda Pharmaceutical	Acido((3s))-6-((¨2,6-dimetil-4-(3-(metilsulfonil)-propoxi)bifenil-3-il)metoxi-2,3-dihidro-1-benzofuran-3-il)acetico o una sal del mismo
TW200815417A (en) *	2006-06-27	2008-04-01	Astrazeneca Ab	New compounds II
EP2025674A1 (fr)	2007-08-15	2009-02-18	sanofi-aventis	Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament
EP2406230A1 (fr)	2009-03-11	2012-01-18	Pfizer Inc.	Indazole amides substitués
CA2761064A1 (fr) *	2009-04-15	2010-10-21	Astrazeneca Ab	Pyrimidines substituees par imidazole utiles dans le traitement de troubles lies a la glycogene synthase kinase 3, tels que la maladie d'alzheimer
WO2011107494A1 (fr)	2010-03-03	2011-09-09	Sanofi	Nouveaux dérivés aromatiques de glycoside, médicaments contenants ces composés, et leur utilisation
EP2582709B1 (fr)	2010-06-18	2018-01-24	Sanofi	Dérivés d'azolopyridin-3-one en tant qu'inhibiteurs de lipases et de phospholipases
US8530413B2 (en)	2010-06-21	2013-09-10	Sanofi	Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en)	2010-07-05	2012-04-16	Sanofi Sa	(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en)	2010-07-05	2012-06-01	Sanofi Sa	Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en)	2010-07-05	2012-04-16	Sanofi Aventis	Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
WO2013037390A1 (fr)	2011-09-12	2013-03-21	Sanofi	Dérivés amides d'acide 6-(4-hydroxyphényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
WO2013045413A1 (fr)	2011-09-27	2013-04-04	Sanofi	Dérivés d'amide d'acide 6-(4-hydroxyphényl)-3-alkyl-1h-pyrazolo[3,4-b] pyridine-4-carboxylique utilisés comme inhibiteurs de kinase
CN103724207B (zh) *	2013-12-20	2016-07-06	北京智博高科生物技术有限公司	苯基苄基醚类衍生物及其制备方法和应用
JP2017524739A (ja)	2014-07-17	2017-08-31	アンセルムＩｎｓｅｒｍ	神経筋接合部関連疾患の処置方法
UY36547A (es)	2015-02-05	2016-06-01	Bayer Cropscience Ag	Derivados heterocíclicos condensados bicíclicos sustituidos por 2-(het)arilo como pesticidas
WO2016207366A1 (fr)	2015-06-26	2016-12-29	INSERM (Institut National de la Santé et de la Recherche Médicale)	Méthodes et compositions pharmaceutiques de traitement d'infections virales
JP6913076B2 (ja)	2015-08-07	2021-08-04	バイエル・クロップサイエンス・アクチェンゲゼルシャフト	有害生物防除剤としての２−（ヘタ）アリール−置換縮合ヘテロ環誘導体
GB201519573D0 (en)	2015-11-05	2015-12-23	King S College London	Combination

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0021726D0 (en) *	2000-09-05	2000-10-18	Astrazeneca Ab	Chemical compounds
JP4570955B2 (ja) *	2002-07-09	2010-10-27	バーテクスファーマスーティカルズインコーポレイテッド	プロテインキナーゼ阻害活性を持つイミダゾール類
AU2004261482A1 (en) *	2003-07-30	2005-02-10	Cyclacel Limited	Pyridinylamino-pyrimidine derivatives as protein kinase inhibitors
BRPI0415759A (pt) *	2003-10-21	2006-12-19	Cyclacel Ltd	compostos de pirimidin-4-il-3,4-tiona e uso dos mesmos na terapia
GB0402653D0 (en) *	2004-02-06	2004-03-10	Cyclacel Ltd	Compounds
US20090099160A1 (en) *	2004-12-17	2009-04-16	David Andrews	4-(4-(Imidazol-4-Yl) Pyrimidin-2-Ylamino) Benzamides as CDK Inhibitors
GB0504753D0 (en) *	2005-03-08	2005-04-13	Astrazeneca Ab	Chemical compounds
AR058073A1 (es) *	2005-10-03	2008-01-23	Astrazeneca Ab	Derivados de imidazol 5-il-pirimidina, procesos de obtencion, composiciones farmaceuticas y usos
TW200815417A (en) *	2006-06-27	2008-04-01	Astrazeneca Ab	New compounds II

2007
- 2007-06-21 TW TW096122338A patent/TW200815418A/zh unknown
- 2007-06-26 UY UY30440A patent/UY30440A1/es unknown
- 2007-06-26 MX MX2008015720A patent/MX2008015720A/es not_active Application Discontinuation
- 2007-06-26 AR ARP070102831A patent/AR061652A1/es not_active Application Discontinuation
- 2007-06-26 JP JP2009518044A patent/JP2009542638A/ja active Pending
- 2007-06-26 BR BRPI0713576-9A patent/BRPI0713576A2/pt not_active IP Right Cessation
- 2007-06-26 CN CNA2007800322107A patent/CN101511825A/zh active Pending
- 2007-06-26 AU AU2007265731A patent/AU2007265731A1/en not_active Abandoned
- 2007-06-26 CA CA002655441A patent/CA2655441A1/fr not_active Abandoned
- 2007-06-26 RU RU2008148902/04A patent/RU2008148902A/ru not_active Application Discontinuation
- 2007-06-26 WO PCT/SE2007/000620 patent/WO2008002244A2/fr not_active Ceased
- 2007-06-26 EP EP07748281A patent/EP2046782A4/fr not_active Withdrawn
- 2007-06-26 KR KR1020097001642A patent/KR20090024817A/ko not_active Withdrawn
- 2007-06-26 CL CL200701881A patent/CL2007001881A1/es unknown
- 2007-06-27 US US11/769,102 patent/US20080188502A1/en not_active Abandoned
2008
- 2008-12-02 IL IL195666A patent/IL195666A0/en unknown
- 2008-12-10 ZA ZA200810484A patent/ZA200810484B/xx unknown
- 2008-12-12 EC EC2008008973A patent/ECSP088973A/es unknown
- 2008-12-17 CO CO08134161A patent/CO6140059A2/es unknown
2009
- 2009-01-21 NO NO20090327A patent/NO20090327L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2008002244A2 (fr)	2008-01-03
MX2008015720A (es)	2008-12-19
CN101511825A (zh)	2009-08-19
KR20090024817A (ko)	2009-03-09
AR061652A1 (es)	2008-09-10
RU2008148902A (ru)	2010-08-10
ECSP088973A (es)	2009-01-30
US20080188502A1 (en)	2008-08-07
WO2008002244A8 (fr)	2008-10-09
IL195666A0 (en)	2009-09-01
CA2655441A1 (fr)	2008-01-03
BRPI0713576A2 (pt)	2012-10-23
CO6140059A2 (es)	2010-03-19
WO2008002244A3 (fr)	2008-02-14
TW200815418A (en)	2008-04-01
CL2007001881A1 (es)	2008-02-08
ZA200810484B (en)	2009-08-26
JP2009542638A (ja)	2009-12-03
AU2007265731A1 (en)	2008-01-03
UY30440A1 (es)	2008-01-31
EP2046782A4 (fr)	2010-10-13
EP2046782A2 (fr)	2009-04-15

Publication	Publication Date	Title
NO20090327L (no)	2009-02-09	Nye forbindelser 384
NO20090328L (no)	2009-01-26	Nye forbindelser 385
NO20070224L (no)	2007-04-02	2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20083411L (no)	2004-03-19	Indaneddiksyrederivater og deres anvendelse som farmasoytiske midler, intermediater og fremgangsmater for fremstilling
NO20091560L (no)	2009-05-15	Biaryleterureaforbindelser
NO20082496L (no)	2008-07-24	Pyrazinderivater
NO20044731L (no)	2004-12-30	Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere
NO20074592L (no)	2007-10-19	Acetylenyl-pyrazolo-pyrimidinderivater som mGluR2-antagonister
NO20072978L (no)	2007-06-27	Nye betuinderivater, preparat derav og anvendelse derav
TW200745111A (en)	2007-12-16	New compounds
CY1109962T1 (el)	2014-09-10	Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
NO20063761L (no)	2006-10-23	Sulfonamidderivater for behandling av sykdommer
NO20076638L (no)	2007-12-21	Nye 8-sulfonylamino-3-aminosubstituerte kroman- eller tetrahydronaftalenderivater som modulerer 5HT6-reseptoren
NO20063468L (no)	2006-11-15	Triazolforbindelser og deres anvendelse som metabotrofe glutamatreseptorantagonister
NO20066055L (no)	2007-01-24	Pyridinderivater
NO20063928L (no)	2006-10-31	Substituerte kinolinforbindelser
NO20092342L (no)	2009-07-02	Azaspiroderivativater
EA200870302A1 (ru)	2009-02-27	1,3-диоксанкарбоновые кислоты
IS2376B (is)	2008-07-15	Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfsnæmissjúkdómi
NO20062905L (no)	2006-06-21	Nye hydroksaminsyreestere og farmasoytisk anvendelse derav
NO20056192L (no)	2005-12-27	Kapaseinhibitorer og anvendelse derav
NO20055977L (no)	2006-02-16	Nye benzimidazolderivater
CY1109366T1 (el)	2014-07-02	Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
NO20083708L (no)	2008-09-23	4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
SE0100569D0 (sv)	2001-02-20	New compounds

Legal Events

Date	Code	Title	Description
2012-01-23	FC2A	Withdrawal, rejection or dismissal of laid open patent application